Elevance Health (ELV) vs Humana (HUM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Humana (HUM) has outperformed Elevance Health (ELV) over the past year, gaining 71.7% versus a gain of 22.6%. Over five years, ELV leads with a -5.1% price change compared with -9.0% for HUM. Elevance Health is the larger company by market cap ($85.23 billion vs $46.84 billion), about 1.8 times the size.
On valuation, Elevance Health trades at a lower forward P/E (13.0x vs 21.1x for Humana). Elevance Health offers the higher dividend yield (1.74% vs 0.91%). Elevance Health converts more of its revenue into profit, with a net margin of 2.8% versus 0.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELV | HUM |
|---|---|---|
| Share price | $394.48 | $390.00 |
| Market cap | $85.23B | $46.84B |
| 1-day change | +1.11% | +2.63% |
| YTD return | +12.53% | +52.27% |
| 1-year return | +22.61% | +71.73% |
| 5-year return | -5.06% | -8.98% |
| P/E ratio (TTM) | 16.75 | 38.05 |
| Forward P/E | 13.02 | 21.06 |
| EPS (TTM) | $23.55 | $10.25 |
| Dividend yield | 1.74% | 0.91% |
| Annual dividend | $6.87 | $3.54 |
| Revenue (latest FY) | $199.13B | $129.66B |
| Revenue growth (YoY) | +12.49% | +10.11% |
| Net income (latest FY) | $5.66B | $1.19B |
| Gross margin | 89.36% | — |
| Operating margin | 3.62% | 2.09% |
| Net margin | 2.84% | 0.92% |
| 52-week high | $450.69 | $462.87 |
| 52-week low | $274.84 | $163.11 |
| Distance from 52-week high | -12.47% | -15.74% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +22.28% | +30.98% |
| Average volume | 1.31M | 1.46M |
| Shares outstanding | 216.06M | 120.10M |
| Employees | 96,129 | 67,060 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HUM has outperformed ELV by 49.1 percentage points over the past year.
- Humana trades at a higher earnings multiple (38.0x vs 16.8x trailing P/E).
About Elevance Health
ELV stock →Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Health Care · Medical Specialities · 96,129 employees
About Humana
HUM stock →Humana Inc. provides medical and specialty insurance products in the United States.
Health Care · Medical Specialities · 67,060 employees
ELV vs HUM FAQ
Which is bigger, Elevance Health or Humana?
Elevance Health (ELV) is larger, with a market capitalization of $85.23B compared with $46.84B for Humana (HUM).
Which stock has performed better over the past year, ELV or HUM?
HUM returned +71.73% over the past 12 months, compared with +22.61% for ELV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ELV or HUM?
ELV has the lower trailing P/E at 16.8, versus 38.0 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Elevance Health or Humana?
Elevance Health has the higher yield at 1.74%, compared with 0.91% for Humana.
Are Elevance Health and Humana in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.